Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy

[1]  D. G. MacArthur,et al.  Guidelines for investigating causality of sequence variants in human disease , 2014, Nature.

[2]  J. Kautzner,et al.  Isolated X-Linked Hypertrophic Cardiomyopathy Caused by a Novel Mutation of the Four-and-a-Half LIM Domain 1 Gene , 2013, Circulation. Cardiovascular genetics.

[3]  G. Bonne,et al.  ‘State-of-the-heart’ of cardiac laminopathies , 2013, Current opinion in cardiology.

[4]  Katherine H. Schreiber,et al.  When Lamins Go Bad: Nuclear Structure and Disease , 2013, Cell.

[5]  Thomas Meitinger,et al.  Calmodulin Mutations Associated With Recurrent Cardiac Arrest in Infants , 2013, Circulation.

[6]  Eloisa Arbustini,et al.  Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy. , 2012, Human molecular genetics.

[7]  H. Katus,et al.  Mechanisms of disease: hypertrophic cardiomyopathy , 2012, Nature Reviews Cardiology.

[8]  K. Downes,et al.  A mutation in the thyroid hormone receptor alpha gene. , 2012, The New England journal of medicine.

[9]  H. Worman.  Nuclear lamins and laminopathies , 2012, The Journal of pathology.

[10]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[11]  E. Giné,et al.  Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia , 2011, Nature Genetics.

[12]  Juliane C. Dohm,et al.  Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia , 2011, Nature.

[13]  V. Quesada,et al.  Exome sequencing and functional analysis identifies BANF1 mutation as the cause of a hereditary progeroid syndrome. , 2011, American journal of human genetics.

[14]  J. Seidman,et al.  Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history. , 2011, Circulation research.

[15]  Wei Zhang,et al.  A novel heterozygous deletion–insertion mutation (2695–2712 del/GTTTGT ins) in exon 18 of the filamin C gene causes filaminopathy in a large Chinese family , 2010, Neuromuscular Disorders.

[16]  J. Stark.  Thirty Years Before Topics in Language Disorders: A Personal History , 2010 .

[17]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[18]  I. Ferrer,et al.  In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy , 2009, European Journal of Human Genetics.

[19]  Nancy F. Hansen,et al.  Accurate Whole Human Genome Sequencing using Reversible Terminator Chemistry , 2008, Nature.

[20]  C. Heyer,et al.  Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients. , 2007, Brain : a journal of neurology.

[21]  S. Shete,et al.  Myozenin 2 Is a Novel Gene for Human Hypertrophic Cardiomyopathy , 2007, Circulation research.

[22]  L. Kunkel,et al.  Loss of FilaminC (FLNc) Results in Severe Defects in Myogenesis and Myotube Structure , 2006, Molecular and Cellular Biology.

[23]  Hanns Lochmüller,et al.  A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy. , 2005, American journal of human genetics.

[24]  F. Mastaglia,et al.  Mutations in the slow skeletal muscle fiber myosin heavy chain gene (MYH7) cause laing early-onset distal myopathy (MPD1). , 2004, American journal of human genetics.

[25]  Barry J Maron,et al.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G , 2003, Journal of the American College of Cardiology.

[26]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[27]  M. Burch,et al.  Hypertrophic cardiomyopathy. , 1994, Archives of disease in childhood.

[28]  Marinos C. Dalakas,et al.  Muscle biopsy — a practical approach , 1986, The Ulster Medical Journal.

[29]  J. Ott,et al.  Strategies for multilocus linkage analysis in humans. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Marian,et al.  Pathogenesis of hypertrophic cardiomyopathy caused by myozenin 2 mutations is independent of calcineurin activity. , 2013, Cardiovascular research.

[31]  M. Maron.  A paradigm shift in our understanding of the development of the hypertrophic cardiomyopathy phenotype?: not so fast! , 2013, Circulation.

[32]  M. Vorgerd,et al.  Filamin C-related myopathies: pathology and mechanisms , 2012, Acta Neuropathologica.

[33]  I. Nonaka,et al.  Filamin C plays an essential role in the maintenance of the structural integrity of cardiac and skeletal muscles, revealed by the medaka mutant zacro. , 2012, Developmental biology.

[34]  Claude-Alain H. Roten,et al.  Theoretical and practical advances in genome halving , 2004 .

[35]  L. Mestroni,et al.  Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. , 1999, European heart journal.